Copernicus Capital Management »

Horizon Therapeutics shares owned by Copernicus Capital Management

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Copernicus Capital Management from 13F filings

Historical chart of Copernicus Capital Management investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Copernicus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Copernicus Capital Management

Quarter filed Position value Share count Share price at filing
2021-09-30 $657k 6.0k 109.50
2021-06-30 $468k 5.0k 93.60
2020-06-30 $4.7M 85k 55.59

More positions owned by Copernicus Capital Management

Pfizer (PFE)
Thermo Fisher Scientific (TMO)
Teladoc (TDOC)
BioMarin Pharmaceutical (BMRN)
Johnson & Johnson (JNJ)
Fate Therapeutics (FATE)
Horizon Therapeutics Pub L SHS
Arcus Biosciences Incorporated (RCUS)
Allogene Therapeutics (ALLO)
Medtronic SHS (MDT)
Proqr Thrapeutics N V Shs Euro (PRQR)
Immatics SHS (IMTX)
Amicus Therapeutics (FOLD)

View all positions for Copernicus Capital Management

Top funds holding Horizon Therapeutics

Huntington National Bank

View all funds holding Horizon Therapeutics